Results 161 to 170 of about 117,406 (297)

Eliminating single points of trust: a hybrid quantum and post-quantum blockchain with distributed key generation. [PDF]

Sci Rep
Goh KW, Khan BUI, Khan AR, Putra DS, P P FR, Bhuyian MA.   +5 more
europepmc   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

SelectVote Byzantine Fault Tolerance for Evidence Custody: Virtual Voting Consensus with Environmental Compensation. [PDF]

Sensors (Basel)
Onyeashie BI, Leimich P, McKeown S, Russell G.   +3 more
europepmc   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

The Impact of Expert Witness Knowledge on Perceived Credibility: Implications for Not Guilty by Reason of Insanity (NGRI) Endorsement. [PDF]

Behav Sci (Basel)
Cain CF, Smith OKH.
europepmc   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Cross-platform certification of the qubit space with a minimal number of parameters. [PDF]

Sci Rep
Rybotycki T, Białecki T, Batle J, Tworzydło J, Bednorz A.   +4 more
europepmc   +1 more source

Cavitation Inception Witnessed by Sound Pressure Level both in Model Test and Prototype Observation [PDF]

, 2001
Dong Zhang, Zhiping Liu, Tailai Jin
openalex  

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Five <i>Leptospira</i> spp. Antibody Point-of-Care Tests in Healthy Dogs Reveal Different Results After Revaccination Against Leptospirosis. [PDF]

Microorganisms
Schmitt KG, Bergmann M, van der Linden H, Ahmed AA, Straubinger RK, Zablotski Y, Hartmann K.   +6 more
europepmc   +1 more source